Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 | P35372 | 3/20 | 1.00 |
| ▸ | CYP3A4 | P08684 | 2/20 | 1.00 |
| ▸ | LMNA | P02545 | 2/20 | 1.00 |
| ▸ | HTR1A | P08908 | 2/20 | 1.00 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 1.00 |
| ▸ | SLC6A2 | P23975 | 2/20 | 1.00 |
| ▸ | SLC6A4 | P31645 | 2/20 | 1.00 |
| ▸ | ADRA1A | P35348 | 2/20 | 1.00 |
| ▸ | DRD3 | P35462 | 2/20 | 1.00 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 1.00 |
| ▸ | KCNH2 | Q12809 | 2/20 | 1.00 |
| ▸ | CASR | P41180 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
| ▸ | CYP2D6 | P10635 | 2/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 2/20 | 1.00 |
| ▸ | CHRM2 | P08172 | 1/20 | 1.00 |
| ▸ | ADRA2A | P08913 | 1/20 | 1.00 |
| ▸ | CHRM1 | P11229 | 1/20 | 1.00 |
| ▸ | SMPD1 | P17405 | 1/20 | 1.00 |
| ▸ | DRD1 | P21728 | 1/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Fendiline SCHEMBL5053865 | 1.00 | OPRM1 (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| Fendiline SCHEMBL14415808 | 1.00 | OPRM1 (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| Fendiline SCHEMBL14415809 | 1.00 | OPRM1 (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| Fendiline SCHEMBL15571059 | 0.98 | KMT2A (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| Fendiline SCHEMBL15572599 | 0.98 | KMT2A (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| Fendiline SCHEMBL666530 | 0.98 | KMT2A (1.00) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| SCHEMBL9660642 | 0.93 | HTR1A (0.86) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| SCHEMBL9662753 | 0.91 | HTR1A (0.83) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| SCHEMBL9661837 | 0.89 | HTR1A (0.80) | OPRM1CYP3A4LMNAHTR1AADORA3 | |
| SCHEMBL9662448 | 0.89 | LMNA (0.80) | OPRM1CYP3A4LMNAHTR1AADORA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Appears in 6213 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4741492-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2026-05-13 | — | — | EP | claimed |
| EP-4255391-B1 | LUMINOL FOR USE IN THE TREATMENT OF SEQUELAE OF A SARS-COV-2 INFECTION | METRIOPHARM AG (CH) | 2026-05-06 | — | — | EP | claimed |
| US-12550885-B2 | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells | UNIVERSITY OF CINCINNATI (US) | 2026-02-17 | — | — | US | claimed |
| EP-4658278-A1 | SELECTIVE FIASMA TREATMENT | Valo Health, Inc. (US) | 2025-12-10 | — | — | EP | claimed |
| EP-4648769-A2 | NECROSIS INHIBITOR | Linkgevity Limited (GB) | 2025-11-19 | — | — | EP | claimed |
| EP-4615506-A1 | USE OF GSK-3 ACTIVATIOR TO MODULATE PROTEASOME ACTIVITY TO PREVENT AGEING ASSOCIATED CONDITIONS AND DISEASES | Sahin, Fikret (TR) | 2025-09-17 | — | — | EP | claimed |
| CN-118130678-B | Liquid chromatography-mass spectrometry detection method for 14 drugs of dizziness, syncope and cerebral apoplexy in blood | 中国民用航空局民用航空医学中心 | 2025-06-10 | — | — | CN | claimed |
| US-20250152591-A1 | TREATMENT OF HEMATOLOGICAL MALIGNANCIES WITH MENIN INHIBITORS AND P-GLYCOPROTEIN INHIBITORS | KURA ONCOLOGY INC (US) | 2025-05-15 | — | — | US | claimed |
| WO-2025097070-A1 | ORAL DOSAGE FORM WITH CATIONICALLY CHARGEABLE HYDROGEL FOR DELIVERY OF ACTIVE AGENT | ENTREGA INC. (US) | 2025-05-08 | — | — | WO | claimed |
| CN-119515952-A | Automatic identification method and device for thickness of cable insulating layer | 镇江绿建工程咨询有限公司 | 2025-02-25 | — | — | CN | claimed |
| WO-1993003711-A1 | DOSAGE FORM FOR DELIVERING DRUG IN SHORT-TIME PERIOD | ALZA CORPORATION (US) | 1993-03-04 | — | — | WO | claimed |
| US-5190765-A | Latent Drug Delivery | ALZA CORPORATION (US) | 1993-03-02 | — | — | US | claimed |
| US-5178867-A | Dosage form for delivering drug in short-time period | ALZA CORPORATION (US) | 1993-01-12 | — | — | US | claimed |
| WO-1993000071-A1 | DOSAGE FORM FOR A DELAYED DRUG DELIVERY | ALZA CORPORATION (US) | 1993-01-07 | — | — | WO | claimed |
| US-5160744-A | Sustained release by coating drug in polyoxyethylene glycol and another polymer that swells and expands and pushes the drug out | ALZA CORPORATION (US) | 1992-11-03 | — | — | US | claimed |
| EP-0397848-A1 | METHOD OF ATTACHING A COMPOSITE ELASTIC MATERIAL TO AN ARTICLE. | KIMBERLY CLARK CO (US) | 1990-11-22 | — | — | EP | claimed |
| US-4851404-A | USING CALCIUM PLOCKERS | MILES INC. (US) | 1989-07-25 | — | — | US | claimed |
| EP-0078820-B1 | INCLUSION COMPLEXES OF N-(1-PHENYLETHYL)-3,3-DIPHENYLPROPYLAMINE RESPECTIVELY THE HYDROCHLORIDE THEREOF WITH CYCLODEXTRIN, A PROCESS FOR THE PREPARATION OF THESE INCLUSION COMPLEXES AS WELL AS PHARMACEUTICAL PREPARATIONS CONTAINING THESE INCLUSION COMPLEXES | CHINOIN Gyogyszer és Vegyészeti Termékek Gyára RT. (HU) | 1987-12-09 | — | — | EP | claimed |
| US-4518588-A | CORONARY DILATOR CALCIUM ANTAGONIST | CHINOIN GYOGYSZER ES VEGYESZETI TERMEKEK GYARA RT. (HU) | 1985-05-21 | — | — | US | claimed |
| EP-0008252-B1 | ROTATING HYDRAULIC DISTRIBUTOR, PARTICULARLY FOR POWER-ASSISTED STEERING MECHANISMS | BENDIBERICA S.A. (ES) | 1982-02-24 | — | — | EP | claimed |